Central serous chorioretinopathy in a COVID-19-positive patient with torpedo maculopathy and associated oral tadalafil intake

Authors

Pradeep Kumar Panigrahi, Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, SOA (Deemed to be) University, Bhubaneswar, Odisha, India

Abstract

A 46-year-old post-COVID-19-positive male patient presented with sudden onset painless loss of vision in the left eye (LE). There was history of oral tadalafil intake 10 days before vision loss. Clinical and imaging examinations led to the diagnosis of central serous chorioretinopathy with torpedo maculopathy in LE. No active intervention was done. There was complete resolution of neurosensory detachment with improvement of vision 1 month following the presentation.

Recommended Citation

Panigrahi, Pradeep Kumar (2022) "Central serous chorioretinopathy in a COVID-19-positive patient with torpedo maculopathy and associated oral tadalafil intake," Indian Journal of Health Sciences and Biomedical Research KLEU: Vol. 15: Iss. 2, Article 15.
DOI: https://doi.org/10.4103/kleuhsj.kleuhsj_212_21
Available at: https://kleijhsbr.researchcommons.org/journal/vol15/iss2/15

Pages

173

Last Page

175

Copyright

© 2022 Indian Journal of Health Sciences and Biomedical Research KLEU | Published by Wolters Kluwer – Medknow